CHI Advisors LLC - Q3 2023 holdings

$252 Million is the total value of CHI Advisors LLC's 28 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 30.8% .

 Value Shares↓ Weighting
PLRX SellPLIANT THERAPEUTICS INC$52,266,211
-7.5%
3,014,199
-3.3%
20.72%
+20.9%
RPTX SellREPARE THERAPEUTICS INC$35,837,422
+13.0%
2,966,674
-1.1%
14.20%
+47.5%
CGEM  CULLINAN ONCOLOGY INC$30,898,410
-15.9%
3,414,1890.0%12.25%
+9.9%
SellACELYRIN INC$23,014,608
-58.7%
2,262,990
-15.0%
9.12%
-46.0%
BuyORCHARD THERAPEUTICS PLCspon ads new$14,034,773
+256.4%
12,315,654
+1529.6%
5.56%
+365.5%
LRMR  LARIMAR THERAPEUTICS INC$13,487,148
+54.7%
3,414,4680.0%5.35%
+102.0%
KROS BuyKEROS THERAPEUTICS INC$12,995,340
-19.6%
407,633
+1.4%
5.15%
+5.1%
IKNA BuyIKENA ONCOLOGY INC$9,443,445
-32.2%
2,180,934
+2.8%
3.74%
-11.4%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$7,664,750
+95.5%
215,000
+152.9%
3.04%
+155.3%
CMPX  COMPASS THERAPEUTICS INC$5,574,532
-38.1%
2,829,7120.0%2.21%
-19.1%
NewMINERALYS THERAPEUTICS INC$5,405,284568,379
+100.0%
2.14%
INZY BuyINOZYME PHARMA INC$5,334,112
-19.9%
1,270,027
+6.3%
2.11%
+4.7%
BuySYROS PHARMACEUTICALS INC$5,119,170
+111.8%
1,299,359
+69.3%
2.03%
+176.4%
BPMC NewBLUEPRINT MEDICINES CORP$4,664,83592,888
+100.0%
1.85%
LABD SellDIREXION SHS ETF TRdaily s&p biotec$4,635,000
-0.8%
225,000
-30.8%
1.84%
+29.6%
Buy2SEVENTY BIO INC$3,927,867
-54.4%
1,002,007
+17.6%
1.56%
-40.5%
NewMOONLAKE IMMUNOTHERAPEUTICSclass a ord$3,420,00060,000
+100.0%
1.36%
OVID  OVID THERAPEUTICS INC$3,320,916
+17.1%
864,8220.0%1.32%
+52.8%
NewSAGIMET BIOSCIENCES INC$3,069,810348,842
+100.0%
1.22%
 OMEGA THERAPEUTICS INC$2,270,146
-61.6%
1,055,8820.0%0.90%
-49.8%
BDTX SellBLACK DIAMOND THERAPEUTICS I$2,066,400
-45.4%
720,000
-4.0%
0.82%
-28.7%
SellRALLYBIO CORP$1,316,774
-57.1%
390,734
-28.0%
0.52%
-44.0%
SellDISC MEDICINE INC$1,174,500
-78.9%
25,000
-80.0%
0.47%
-72.4%
GRPH  GRAPHITE BIO INC$572,726
-4.6%
230,9380.0%0.23%
+24.7%
BuyFREELINE THERAPEUTICS HLDGSsponsored ads$372,613
+566.6%
86,654
+300.0%
0.15%
+770.6%
DTIL SellPRECISION BIOSCIENCES INC$207,043
-75.5%
606,629
-62.2%
0.08%
-68.0%
RPTX NewREPARE THERAPEUTICS INCcall$157,50050,000
+100.0%
0.06%
PLRX BuyPLIANT THERAPEUTICS INCcall$55,000
-66.0%
137,500
+5.5%
0.02%
-55.1%
CRVS ExitCORVUS PHARMACEUTICALS INC$0-200,000
-100.0%
-0.14%
HOOK ExitHOOKIPA PHARMA INC$0-788,740
-100.0%
-0.21%
VECT ExitVECTIVBIO HLDG AG$0-2,782,756
-100.0%
-14.24%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
PRECISION BIOSCIENCES INC17Q3 202313.4%
OVID THERAPEUTICS INC17Q3 20235.8%
CORVUS PHARMACEUTICALS INC16Q2 20231.8%
KEZAR LIFE SCIENCES INC15Q1 20235.8%
PLIANT THERAPEUTICS INC14Q3 202329.2%
REPARE THERAPEUTICS INC14Q3 202330.3%
ORCHARD THERAPEUTICS PLC14Q4 202252.6%
LARIMAR THERAPEUTICS INC14Q3 20239.1%
KEROS THERAPEUTICS INC14Q3 20238.6%
INOZYME PHARMA INC13Q3 20239.4%

View CHI Advisors LLC's complete holdings history.

Latest significant ownerships (13-D/G)
CHI Advisors LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Corvus Pharmaceuticals, Inc.February 13, 20232,384,4025.1%
Cullinan Oncology, Inc.February 13, 20233,317,5447.2%
Freeline Therapeutics Holdings plcFebruary 13, 20234,814,4197.4%
Inozyme Pharma, Inc.February 13, 20232,204,8765.5%
Larimar Therapeutics, Inc.February 13, 20233,473,3668.0%
Oncorus, Inc.February 13, 20232,367,4369.1%
Orchard Therapeutics plcFebruary 13, 20237,987,3966.3%
PLIANT THERAPEUTICS, INC.February 13, 20233,199,8926.6%
Repare Therapeutics Inc.February 13, 20232,800,1266.7%
VectivBio Holding AGFebruary 13, 20235,492,8938.8%

View CHI Advisors LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR/A2023-08-22
13F-HR2023-08-11
13F-HR2023-05-11
SC 13G/A2023-02-13
SC 13G/A2023-02-13
SC 13G/A2023-02-13
SC 13G/A2023-02-13
SC 13G/A2023-02-13
SC 13G/A2023-02-13

View CHI Advisors LLC's complete filings history.

Compare quarters

Export CHI Advisors LLC's holdings